Literature DB >> 27915109

Decreased myeloid dendritic cells indicate a poor prognosis in patients with severe fever with thrombocytopenia syndrome.

Wenjing Zhang1, Mengmeng Li1, Shue Xiong1, Hua Wang1, Yan Xiong1, Mingyue Li1, Mengji Lu2, Dongliang Yang1, Cheng Peng3, Xin Zheng4.   

Abstract

OBJECTIVES: Severe fever with thrombocytopenia syndrome (SFTS) is a newly emerging infectious disease caused by a novel bunyavirus in which host immune system suppression is thought to be crucial in the development of disease. This study was designed to study the frequencies and activation status of dendritic cells (DCs) at different stages of SFTS and their association with disease severity.
METHODS: All confirmed SFTS patients (N=115) were recruited from the Wuhan Union Hospital in 2015; routine laboratory parameters were collected. The frequencies, phenotypes, and subsets of circulating DCs, including myeloid and plasmacytoid dendritic cells (mDCs and pDCs), were analyzed by flow cytometry. Serum levels of interleukin (IL)-6, IL-10, and tumor necrosis factor alpha (TNF-α) were detected by ELISA. The laboratory parameters and other clinical events related to mortality were assessed by multivariate logistic regression analysis and receiver operating characteristic (ROC) curves.
RESULTS: The frequency of circulating mDCs, especially from day 9 after disease onset, could serve as a valuable prognostic biomarker for the outcome in SFTS patients (area under the curve=0.929, p<0.0001). In addition, persistent down-regulation of the co-stimulatory molecules CD80/CD86 on the mDCs was observed during the disease process. Moreover, levels of mDCs were inversely correlated with the production of IL-6, IL-10, and TNF-α and with viral load at admission.
CONCLUSIONS: The present results indicate that DCs might be functionally impaired in SFTS. A decreased level of circulating mDCs was closely correlated with the severity of SFTS.
Copyright © 2016 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Acute phase; Dendritic cell; Mortality; Prognosis; Severe fever with thrombocytopenia syndrome

Mesh:

Substances:

Year:  2016        PMID: 27915109     DOI: 10.1016/j.ijid.2016.11.418

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  10 in total

1.  Depletion but Activation of CD56dimCD16+ NK Cells in Acute Infection with Severe Fever with Thrombocytopenia Syndrome Virus.

Authors:  Mengmeng Li; Yan Xiong; Mingyue Li; Wenjing Zhang; Jia Liu; Yanfang Zhang; Shue Xiong; Congcong Zou; Boyun Liang; Mengji Lu; Dongliang Yang; Cheng Peng; Xin Zheng
Journal:  Virol Sin       Date:  2020-05-19       Impact factor: 4.327

Review 2.  The Endless Wars: Severe Fever With Thrombocytopenia Syndrome Virus, Host Immune and Genetic Factors.

Authors:  Min Wang; Weilong Tan; Jun Li; Liqun Fang; Ming Yue
Journal:  Front Cell Infect Microbiol       Date:  2022-06-15       Impact factor: 6.073

3.  Risk factors associated with fatality of severe fever with thrombocytopenia syndrome: a meta-analysis.

Authors:  Yuxin Chen; Bei Jia; Yong Liu; Rui Huang; Junhao Chen; Chao Wu
Journal:  Oncotarget       Date:  2017-07-11

4.  Deficient humoral responses and disrupted B-cell immunity are associated with fatal SFTSV infection.

Authors:  Peixin Song; Nan Zheng; Yong Liu; Chen Tian; Xilin Wu; Xiaohua Ma; Deyan Chen; Xue Zou; Guiyang Wang; Huanru Wang; Yongyang Zhang; Sufang Lu; Chao Wu; Zhiwei Wu
Journal:  Nat Commun       Date:  2018-08-20       Impact factor: 14.919

Review 5.  Overview of the immunological mechanism underlying severe fever with thrombocytopenia syndrome (Review).

Authors:  Tao Yang; Huaying Huang; Longfeng Jiang; Jun Li
Journal:  Int J Mol Med       Date:  2022-07-20       Impact factor: 5.314

Review 6.  Immune escape mechanisms of severe fever with thrombocytopenia syndrome virus.

Authors:  Tong Wang; Ling Xu; Bin Zhu; Junzhong Wang; Xin Zheng
Journal:  Front Immunol       Date:  2022-07-28       Impact factor: 8.786

Review 7.  Factors and outcomes in Severe Fever with Thrombocytopenia Syndrome (SFTS): A systematic review.

Authors:  Herwati Dualis; Abraham Chin Zefong; Lim Kai Joo; Narinderjeet Kaur Dadar Singh; Syed Sharizman Syed Abdul Rahim; Richard Avoi; Mohammad Saffree Jeffree; Mohd Rohaizat Hassan; Mohd Yusof Ibrahim; Azizan Omar
Journal:  Ann Med Surg (Lond)       Date:  2021-06-11

8.  CD4 T cell loss and Th2 and Th17 bias are associated with the severity of severe fever with thrombocytopenia syndrome (SFTS).

Authors:  Meng-Meng Li; Wen-Jing Zhang; Xiu-Fang Weng; Ming-Yue Li; Jia Liu; Yan Xiong; Shu-E Xiong; Cong-Cong Zou; Hua Wang; Meng-Ji Lu; Dong-Liang Yang; Cheng Peng; Xin Zheng
Journal:  Clin Immunol       Date:  2018-07-20       Impact factor: 3.969

Review 9.  Immune Modulation and Immune-Mediated Pathogenesis of Emerging Tickborne Banyangviruses.

Authors:  Crystal A Mendoza; Hideki Ebihara; Satoko Yamaoka
Journal:  Vaccines (Basel)       Date:  2019-09-20

10.  Circulating Plasmacytoid and Conventional Dendritic Cells Are Numerically and Functionally Deficient in Patients With Scrub Typhus.

Authors:  Seung-Ji Kang; Ki-Jeong Park; Hye-Mi Jin; Young-Nan Cho; Tae Hoon Oh; Seong Eun Kim; Uh Jin Kim; Kyung-Hwa Park; Sook-In Jung; Tae-Ok Kim; Hyo Shin Kim; Young-Goun Jo; Jae Kyun Ju; Seung-Jung Kee; Yong-Wook Park
Journal:  Front Immunol       Date:  2021-07-01       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.